152 related articles for article (PubMed ID: 16441474)
1. Validation of a symptom diary for patients with gastro-oesophageal reflux disease.
Puhan MA; Guyatt GH; Armstrong D; Wiklund I; Fallone CA; Heels-Ansdell D; Degl'Innocenti A; Veldhuyzen van Zanten SJ; Tanser L; Barkun AN; Chiba N; Austin P; El-Dika S; Schünemann HJ
Aliment Pharmacol Ther; 2006 Feb; 23(4):531-41. PubMed ID: 16441474
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
Pace F; Negrini C; Wiklund I; Rossi C; Savarino V;
Aliment Pharmacol Ther; 2005 Aug; 22(4):349-56. PubMed ID: 16098002
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
5. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
6. Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.
Chand N; Johnson DA; Tabangin M; Ware JC
Aliment Pharmacol Ther; 2004 Nov; 20(9):969-74. PubMed ID: 15521844
[TBL] [Abstract][Full Text] [Related]
7. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
Malfertheiner P; Nocon M; Vieth M; Stolte M; Jaspersen D; Koelz HR; Labenz J; Leodolter A; Lind T; Richter K; Willich SN
Aliment Pharmacol Ther; 2012 Jan; 35(1):154-64. PubMed ID: 22070159
[TBL] [Abstract][Full Text] [Related]
8. Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease?
Fallone CA; Guyatt GH; Armstrong D; Wiklund I; Degl'Innocenti A; Heels-Ansdell D; Barkun AN; Chiba N; Zanten SJ; El-Dika S; Austin P; Tanser L; Schünemann HJ
Aliment Pharmacol Ther; 2004 Nov; 20(10):1161-9. PubMed ID: 15569119
[TBL] [Abstract][Full Text] [Related]
9. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
[TBL] [Abstract][Full Text] [Related]
10. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire.
van Zanten SV; Armstrong D; Barkun A; Junghard O; White RJ; Wiklund IK
Aliment Pharmacol Ther; 2007 May; 25(9):1087-97. PubMed ID: 17439510
[TBL] [Abstract][Full Text] [Related]
11. Validation of a four-graded scale for severity of heartburn in patients with symptoms of gastroesophageal reflux disease.
Junghard O; Wiklund I
Value Health; 2008; 11(4):765-70. PubMed ID: 18194395
[TBL] [Abstract][Full Text] [Related]
12. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.
Gold BD; Gunasekaran T; Tolia V; Wetzler G; Conter H; Traxler B; Illueca M
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):520-9. PubMed ID: 18030228
[TBL] [Abstract][Full Text] [Related]
13. Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Am J Gastroenterol; 2012 Sep; 107(9):1354-60. PubMed ID: 22777339
[TBL] [Abstract][Full Text] [Related]
14. Effect of baseline symptom severity on patient-reported outcomes in gastroesophageal reflux disease.
Junghard O; Wiklund IK
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):555-60. PubMed ID: 17556901
[TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study.
Nocon M; Labenz J; Jaspersen D; Leodolter A; Richter K; Vieth M; Lind T; Malfertheiner P; Willich SN
Aliment Pharmacol Ther; 2009 Mar; 29(6):662-8. PubMed ID: 19183146
[TBL] [Abstract][Full Text] [Related]
17. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD.
Brozek JL; Guyatt GH; Heels-Ansdell D; Degl'Innocenti A; Armstrong D; Fallone CA; Wiklund I; van Zanten SV; Chiba N; Barkun AN; Akl EA; Schünemann HJ
J Clin Epidemiol; 2009 Jan; 62(1):102-10. PubMed ID: 18619804
[TBL] [Abstract][Full Text] [Related]
18. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
Sarnelli G; De Giorgi F; Efficie E; Aprea G; Masone S; Savarese MF; Esposito I; Russo L; Cuomo R
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):264-8. PubMed ID: 18334868
[TBL] [Abstract][Full Text] [Related]
19. International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.
Bardhan KD; Stanghellini V; Armstrong D; Berghöfer P; Gatz G; Mönnikes H
Digestion; 2007; 75 Suppl 1():48-54. PubMed ID: 17489032
[TBL] [Abstract][Full Text] [Related]
20. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
